ELF3 emerges as a novel prognostic indicator implicated in gastric cancer progression and correlated with unfavorable clinical outcomes

Figure 2 The mRNA expression of E74-like ETS transcription factor 3 was significantly higher in stomach adenocarcinoma samples. A-H: Compared to normal samples as analyzed in relation to patients’ race, gender, age, cancer stage, tumor grade, Helicobacter pylori infection status, TP53 mutation status, and nodal metastasis status. Multiple group comparisons were performed with ANOVA followed by the Bonferroni post hoc test, detailed statistical analysis is provided in Supplementary Table 1. ELF3: E74-like ETS transcription factor 3; STAD: Stomach adenocarcinoma.